Efficacy, side effects and route of administration are more important than frequency of dosing of anti-osteoporosis treatments in determining patient adherence: a critical review of published articles from 1970 to 2009 S. LeeP. GlendenningC. A. Inderjeeth Review 30 June 2010 Pages: 741 - 753
Effects of therapeutic exercise for persons with osteoporotic vertebral fractures: a systematic review K. DusdalJ. GrundmanisS. R. Harris Review 16 December 2010 Pages: 755 - 769
Development and validation of a disease model for postmenopausal osteoporosis A. GauthierJ. A. KanisOn behalf of the Committee of Scientific Advisors, International Osteoporosis Foundation Original Article 11 August 2010 Pages: 771 - 780
Prevalent vertebral fractures predict subsequent radiographic vertebral fractures in postmenopausal Korean women receiving antiresorptive agent S. H. KimH. S. ChoiS.-K. Lim Original Article 09 June 2010 Pages: 781 - 787
Fragility fractures and the osteoporosis care gap in women: the Canadian Multicentre Osteoporosis Study L.-A. FraserG. Ioannidisthe CaMos Research Group Original Article 04 August 2010 Pages: 789 - 796
Change in hip fracture incidence over the last 6 years in France M. MaravicP. TaupinC. Roux Original Article 02 June 2010 Pages: 797 - 801
Proximal hip geometry and hip fracture risk assessment in a Korean population G. I. ImM. J. Lim Original Article 15 June 2010 Pages: 803 - 807
Guidance for the adjustment of FRAX according to the dose of glucocorticoids J. A. KanisH. JohanssonE. V. McCloskey Original Article 13 January 2011 Pages: 809 - 816
Construction of a FRAX® model for the assessment of fracture probability in Canada and implications for treatment W. D. LeslieL. M. LixJ. A. Kanis Original Article 16 December 2010 Pages: 817 - 827
Fracture prediction and calibration of a Canadian FRAX® tool: a population-based report from CaMos L.-A. FraserL. LangsetmoCaMos Research Group Original Article 16 December 2010 Pages: 829 - 837
Spine–hip discordance and fracture risk assessment: a physician-friendly FRAX enhancement W. D. LeslieL. M. LixJ. A. Kanis Original Article 20 October 2010 Pages: 839 - 847
Targeted intervention reduces refracture rates in patients with incident non-vertebral osteoporotic fractures: a 4-year prospective controlled study A. LihH. NandapalanM. J. Seibel Original Article 24 November 2010 Pages: 849 - 858
Effect of vitamin D supplementation on muscle strength: a systematic review and meta-analysis K. A. StocktonK. MengersenK. L. Bennell Original Article 06 October 2010 Pages: 859 - 871
Sunlight exposure or vitamin D supplementation for vitamin D-deficient non-western immigrants: a randomized clinical trial I. S. WichertsA. J. P. BoekeP. Lips Original Article Open access 04 August 2010 Pages: 873 - 882
Maternal vitamin D status affects bone growth in early childhood—a prospective cohort study H. T. ViljakainenT. KorhonenC. Lamberg-Allardt Original Article Open access 10 December 2010 Pages: 883 - 891
Relationship between bone mineral density changes and risk of fractures among patients receiving calcium with or without vitamin D supplementation: a meta-regression V. RabendaO. BruyèreJ.-Y. Reginster Original Article 09 November 2010 Pages: 893 - 901
Use of proton pump inhibitors and risk of hip/femur fracture: a population-based case-control study S. PouwelsA. LalmohamedF. de Vries Original Article Open access 29 June 2010 Pages: 903 - 910
Polymorphisms in the 5′ flank of COL1A1 gene and osteoporosis: meta-analysis of published studies H. JinE. EvangelouS. H. Ralston Original Article 27 August 2010 Pages: 911 - 921
Reduction of whole PTH/intact PTH ratio as a predictor of bone metabolism in cinacalcet treatment of hemodialysis patients with secondary hyperparathyroidism M. KurajohM. InabaY. Nishizawa Original Article 07 May 2010 Pages: 923 - 930
Bone quality is partially recovered after the discontinuation of RANKL administration in rats by increased bone mass on existing trabeculae: an in vivo micro-CT study Graeme M. CampbellMichael S. OminskySteven K. Boyd Original Article 18 May 2010 Pages: 931 - 942
Adherence to osteoporosis drugs and fracture prevention: no evidence of healthy adherer bias in a frail cohort of seniors S. M. CadaretteD. H. SolomonM. A. Brookhart Original Article 08 June 2010 Pages: 943 - 954
Cost-effectiveness of bazedoxifene incorporating the FRAX® algorithm in a European perspective F. BorgströmO. StrömJ. A. Kanis Original Article 08 June 2010 Pages: 955 - 965
Cost-effectiveness of Denosumab for the treatment of postmenopausal osteoporosis B. JönssonO. StrömJ. A. Kanis Original Article 09 October 2010 Pages: 967 - 982
Oral bisphosphonates are associated with reduced mortality after hip fracture L. A. BeaupreD. W. MorrishS. R. Majumdar Original Article 04 November 2010 Pages: 983 - 991
Risk of femoral shaft and subtrochanteric fractures among users of bisphosphonates and raloxifene P. VestergaardF. SchwartzL. Mosekilde Original Article 17 December 2010 Pages: 993 - 1001
Severe osteoporosis treated with teriparatide in a patient affected by recessive epidermolysis bullosa dystrophica L. MorettiA. NotarnicolaB. Moretti Case Report 11 May 2010 Pages: 1003 - 1006